Grace Therapeutics, Inc. 8-K

What Happened
Grace Therapeutics, Inc. (GRCE) filed a Current Report on Form 8-K on April 27, 2026 announcing an update to its corporate presentation. The updated presentation is attached to the filing as Exhibit 99.1 and is incorporated by reference into the Form 8-K. No other operational or financial items (such as earnings, executive changes, mergers, or bankruptcy notices) were reported in this filing.

Key Details

• Filing date: April 27, 2026 (Form 8-K).
• Item reported: 8.01 (Other Events) — updated corporate presentation attached as Exhibit 99.1.
• The filing also includes the Inline XBRL cover page (Exhibit 104).
• The Form 8-K does not report earnings, revenue figures, CEO/CFO changes, mergers, or other material agreements.

Why It Matters
An updated corporate presentation can contain refreshed information about the company’s business strategy, product pipeline, timelines, or financial highlights — so investors should review Exhibit 99.1 to see any material updates. Because this filing does not include earnings or executive-change disclosures, investors looking for quarterly results or management changes should watch for separate filings or press releases. You can view the full presentation and the 8-K on the SEC EDGAR site or the company’s investor relations page.